Transcription factor activation in lymphokine activated killer cells and lymphocytes from patients receiving IL-2 immunotherapy

Cancer Immunology Immunotherapy

Volumn 46, Issue 6, 1998, Pages 327-337

  Nicolet, Charles M ^a   Surfus, Jean M ^a   Hank, Jacquelyn A ^a   Sondel, Paul M ^a  

^a UNIVERSITY OF WISCONSIN   (United States)

Author keywords

Blood; Cellular activation; Human; Human clinical studies; Transcription factors

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 2; PREGNANCY SPECIFIC BETA1 GLYCOPROTEIN; TRANSCRIPTION FACTOR;

ARTICLE; CANCER IMMUNOTHERAPY; CELL ACTIVATION; DRUG EFFECT; DRUG MECHANISM; HUMAN; KIDNEY CARCINOMA; LYMPHOKINE ACTIVATED KILLER CELL; MELANOMA; MONONUCLEAR CELL; PRIORITY JOURNAL;

ANTIBODIES, MONOCLONAL; ANTIBODIES, NEOPLASM; BIOLOGICAL RESPONSE MODIFIERS; CELLS, CULTURED; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOTHERAPY; INTERLEUKIN-2; KILLER CELLS, LYMPHOKINE-ACTIVATED; LYMPHOCYTES; MELANOMA; NF-KAPPA B; SIGNAL TRANSDUCTION; SP1 TRANSCRIPTION FACTOR; STAT1 TRANSCRIPTION FACTOR; STAT2 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION FACTORS;

EID: 0031679927     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002620050494     Document Type: Article

References (48)

1. Albertini MR, Howard SP, Fisch P, Lindstrom MJ, Hank JA, Gould MN, Sondel PM (1993) Modulation of target cell culture conditions alters susceptibility to lymphocyte-mediated lysis. J Immunother 13:243
2. Andrews NC, Faller DV (1991) A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells Nucleic Acids Res 19:2499
3. Angel P, Imagawa M, Chiu R, Stein B, Imbra RJ, Rahmsdorf HJ, Jonat C, Herrlich P, Karin M (1987) Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor. Cell 49:729
4. Arima N, Kuziel WA, Grdina TA, Greene WC (1992) IL-2-induced signal transduction involves the activation of nuclear NF-κB expression. J Immunol 149:83
5. Baldwin AS Jr (1996) The NF-κB and IκB proteins: new discoveries and insights. Annu Rev Immunol 14:649
6. Bauerle P, Henkel T (1994) Function and activation of NF-κB in the immune system. Annu Rev Immunol 12:141
7. Beadling C, Guschin D, Witthuhn BA, Ziemiecki A, Ihle JN, Kerr IM, Cantrell DA (1994) Activation of JAK kinases and STAT proteins by interleukin-2 and interferon a, but not the T cell antigen receptor, in human T lymphocytes. EMBO J 13:5605
8. Brach MA., Arnold C, Kiehntopf M, Gruss H-J, Herrmann F (1993) Transcriptional activation of the macrophage colony-stimulating factor gene by IL-2 is associated with secretion of bioactive macrophage colony-stimulating factor protein by monocytes and involves activation of the transcription factor NF-κB. J Immunol 150:5535
9. Chiu R, Angel P, Karin M (1989) Jun-B differs in its biological properties from, and is a negative regulator of, c-jun. Cell 59:979
10. Clementi E, Bucci E, Citterio G, Landonio G, Consogno G, and Fortis C (1994) Reversible anergy in circulating lymphocytes of cancer patients during interleukin-2 therapy. Cancer Immunol Immunother 39:167
11. DeVita VT Jr, Hellman S, Rosenberg SA (eds) (1993) Cancer: principles and practice of oncology, 4th edn. Lippincott-Raven, Philadelphia, Pa
12. DeVita VT Jr, Hellman S, Rosenberg SA (eds) (1995) Biologic therapy of cancer, 2nd edn. Lippincott, Philadelphia, Pa
13. Dignam JD, Lebovitz RM, Roeder RG (1983) Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res 11:1475
14. Fortis C, Ferrero E, Besana C, Biffi M, Heltai S, Galli L, Borri A, Schoenheit A, Rugarli C (1990) Recombinant interleukin 2 and lymphokine-activated killer cells in renal cancer patients. I. Phenotypic and functional analysis of the peripheral blood mononuclear cells. Cancer Immunol Immunother 32:161
15. Ganchi PA., Sun SC, Greene WC, Ballard DW (1993) A novel NF-κB complex containing p65 homodimers: implications for transcriptional control at the level of subunit dimerization. Mol Cell Biol 13:7826
16. Hagen G, Muller S, Beato M, Suske G (1994) Sp1-mediated transcriptional activation is repressed by Sp3. EMBO J 13:3843
17. Hank JA, Kohler PC, Weil-Hillman G, Rosenthal NS, Moore KH, Storer B, Minkoff D, Bradshaw J, Bechofer R, Sondel, PM (1988) In vivo induction of the lymphokine-activated killer phenomenon: interleukin 2-dependent human non-major histocompatiblity complex-restricted cytotoxicity generated in vivo during administration of human recombinant interleukin 2. Cancer Res 48:1965
18. Hank JA, Weil-Hillman G, Surfus JE, Sosman JA, Sondel PM (1990) Addition of interleukin 2 in vitro augments detection of lymphokine activated killer activity generated in vivo. Cancer Immunol Immunother 31:53
19. Hou J, Schindler U, Henzel WJ, Wong SC, McKnight SL (1995) Identification and purification of human stat proteins activated in response to interleukin-2. Immunity 2:321
20. Hughes CCW, Pober JS (1993) Costimulation of peripheral blood T cell activation by human endothelial cells. J Immunol 150:3148
21. Jackson SP, Tjian R (1988) O-glycosylation of eukaryolic transcription factors: implications for mechanisms of transcriptional regulation. Cell 55:125
22. Jackson SP, MacDonald JJ, Lees-Miller S, Tjian R (1990) GC box binding induces phosphorylation of Sp1 by a DNA-dependent protein kinase. Cell 63:155
23. Johnston JA, Bacon CM, Finbloom DS, Rees RC, Kaplan D, Shibuya K, Ortaldo JR, Gupta S, Chen YQ, Giri JD, O'Shea, JJ (1995) Tyrosine phosphorylation and activation of STAT 5, STAT 3, and Janus kinases by interleukins 2 and 15. Proc Natl Acad Sci USA 92:8705
24. Karin M (1995) The regulation of AP-1 activity by mitogen-activated protein kinases. J Biol Chem 270:16483
25. Kasid A, Director EP, Rosenberg SA (1989) Induction of endogenous cytokine mRNA in circulating peripheral blood mononuclear cells by IL-2 administration to cancer patients. J Immunol 143:736
26. Kornbluth J, Hoover RG (1988) Changes in gene expression associated with IFN-β and IL-2 induced augmentation of human natural killer cell function. J Immunol 141:3234
27. Lallemand D, Spyrou G, Yaniv M, Pfarr CM (1997) Variations in jun and fos protein expression and AP-1 activity in cycling, resting and stimulated fiibroblasts. Oncogene 14:819
28. Leaman DW, Leung S, Li X, Stark GR (1996) Regulation of STAT-dependent pathways by growth factors and cytokines. FASEB J 10:1578
29. Lin J-X, Migone T-S, Tsang M, Friedmann M, Weatherbee JA, Zhou L, Yamauchi A, Bloom ET, Mietz J, John S, Leonard WJ (1995) The role of shared receptor motifs and common stat proteins in the generation of cytokine pleiotropy and redundancy by IL-2, IL-4, IL-7, IL-13, and IL-15. Immunity 2:331
30. Look DC, Pelletier MR, Tidwell RM, Roswit WT, Holtzman MJ (1995) Stat1 depends on transcriptional synergy with Sp1. J Biol Chem 271:30264
31. Lotze MT, Grimm EA, Mazumder A, Strausser IL, Rosenberg SA (1981) Lysis of fresh and cultured autologous tumor by human lymphocytes cultured in T-cell growth factor. Cancer Res 41:4420
32. Minami Y, Kono T, Miyazaki T, Taniguchi T (1993) The IL-2 receptor complex: its structure, function, and target genes. Annu Rev Immunol 11:245
33. Miyazaki T, Liu Z-J, Kawahara A, Minami Y, Yamada K, Tsujimoto Y, Barsoumian EL, Perlmutter RM, and Taniguchi T (1995) Three distinct IL-2 signaling pathways mediated by bcl-2, c-myc, and lck cooperate in hematopoietic cell proliferation. Cell 81:223
34. Moore NC, Girdlestone J, Anderson G, Owen JJT, Jenkinson EJ (1995) Stimulation of thymocytes before and after positive selection results in the induction of different NF-κB/Rel protein complexes. J Immunol 155:4653
35. Nielsen M, Svejgaard A, Skov S, Odum N (1994) Interleukin-2 induces tyrosine phosphorylation and nuclear translocation of stat3 in human T lymphocytes. Eur J Immunol 24:3082
36. Perkins N, Agranoff A, Pascal E, Nabel G (1994) An interaction between the DNA-binding domains of RelA (p65) and Sp1 mediates HIV gene activation. Mol Cell Biol 14:6570
37. Rosenstein M., Yron I, Kaufmann Y, Rosenberg SA (1984) Lymphokine activated killer cells: lysis of fresh syngeneic natural killer-resistant murine tumor cells by lymphocytes cultured in interleukin 2. Cancer Res. 44:1946
38. Sambrook J, Fritsch EF, Maniatis T (eds) (1989) Molecular cloning: a laboratory manual, 2nd edn. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
39. Schutte J, Viallet J, Nau M, Segal S, Fedorko J, Minna J (1989) Jun-B inhibits and c-fos stimulates the transforming and trans-activating activities of c-jun. Cell 59:987
40. Slansky JE, Farnham PJ (1996) Transcriptional regulation of the DHFR gene. Bioessays 18:55
41. Smith KA, Cantrell, DA (1985). Interleukin 2 regulates its own receptor. Proc Natl Acad Sci USA 82:864
42. Sondel PM, Hank JA, Kohler PC, Chen BP, Minkoff DZ, Molenda JA (1986) Destruction of autologous human lymphocytes by interleukin 2-activated cytotoxic cells. J Immunol 137:502
43. Sondel PM, Kohler PC, Hank JA, Moore KH, Rosenthal NS, Sosman JA, Bechhofer R, Storer B (1988) Clinical and immunological effects of recombinant interleukin 2 given by repetitive weekly cycles to patients with cancer. Cancer Res 48:2561
44. Sugamura K, Asao H, Kondo M, Tanaka N, Ishii N, Ohbo K, Nakamura M, Takeshita T (1996) The interleukin 2 receptor g chain: its role in the multiple cytokine receptor complexes and T cell development in XSCID. Annu Rev Immunol 14:179
45. Taniguchi T, Minami Y (1993) The IL-2/IL-2 receptor system: a current overview. Cell 73:5
46. Verma IM, Stevenson JK, Schwarz EM, Van Antwerp D, Miyamoto S (1995) Rel/NF-κB/IκB family: intimate tales of association and dissociation. Genes Dev 9:2723
47. Weil-Hillman G, Hank JA, Rosenthal NS, Sondel PM (1988) Transient decrease in IL-2 responsive lymphocytes 24 hours after initiation of continuous IL-2 infusion in cancer patients. J Biol Response Mod 7:424
48. Whitmarsh AJ, Davis RJ (1996) Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways. J Mol Med 74:589